| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5502556 | Journal of the Neurological Sciences | 2017 | 14 Pages |
Abstract
CVT is an uncommon neurological condition and is often complicated by associated intraparenchymal hemorrhage. Although not recommended in current guidelines, apixaban may be a safe and effective option for the treatment of CVT.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Shishir Keekana Rao, Mohammad Ibrahim, Claudia M. Hanni, Kushak Suchdev, Dennis Parker, Kumar Rajamani, Wazim Mohamed,